Dr. Ahmed’s approach is rooted in collaboration with community members, local organizations, and city leaders. Rather than ...

Zurich, June 19, 2025 (GLOBE NEWSWIRE) -- Superlab Suisse has announced the opening of its fourth Swiss laboratory facility ...

The talk will take place at the R&D Procurement & Sourcing in Pharma Summit at 10:00 a.m. on June 26. It will be moderated by Kleida Martiro, Partner at Glasswing Ventures and panelists include ...

As the fitness industry undergoes a paradigm shift towards safety, longevity, and natural enhancement, a new class of ...

About Katie Ledecky Katie Ledecky is a nine-time Olympic gold medalist and 21-time world champion swimmer. Katie is a strong ...

Unyte Health, a leader in nervous system health technology and sound-based interventions, is proud to announce the launch of the Sonocea® Enhanced Rest and Restore Protocol™ (RRP), a revolutionary ...

PHILADELPHIA, June 19, 2025 (GLOBE NEWSWIRE) -- The Veterinary Health Center at Kansas State University (K-State’s VHC), a leading veterinary teaching hospital in the United States, has transitioned ...

General Catalyst’s Customer Value Fund (CVF) provides late-stage companies with a balance sheet for growth. CVF pre-funds companies’ sales and marketing and is paid back by a capped share of the ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet ...

The RSUs will vest over four years, with 25% of the shares vesting on the first anniversary of the applicable vesting commencement date, and the balance vesting annually thereafter in three equal ...

Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease ...

Nusano will supply dGenThera with At-211 in quantities sufficient to enable the company’s ongoing preclinical studies, first‑in‑human trials, and subsequent clinical development. The agreement ...